Tibor Pál

3.3k citations

87 papers · 2.7k indexed · h-index 33

Impact in

Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria
Endocrinology top 0.2%
- Escherichia coli research studies
- Vibrio bacteria research studies

Papers in

Endocrinology 56
- Escherichia coli research studies 38
- Enterobacteriaceae and Cronobacter Research 11
- Vibrio bacteria research studies 8
Molecular Medicine 40
- Antibiotic Resistance in Bacteria 40

Co-authors: Ágnes Sonnevend Akela Ghazawi J. Michael Conlon Rayhan Hashmey Vincent O. Rotimi Wafaa Jamal Sanjukta Ghosh Thomas L. Hale
Journals: Journal of Clinical Microbiology (5 papers)Journal of Medical Microbiology (4 papers)International Journal of Antimicrobial Agents (4 papers)International Journal of Infectious Diseases (3 papers)Diagnostic Microbiology and Infectious Disease (3 papers)
Partner nations: United Arab Emirates Hungary Kuwait

In The Last Decade

Tibor Pál

87 papers receiving 2.6k citations

Peers

Countries citing papers authored by Tibor Pál

Since Specialization

Citations

This map shows the geographic impact of Tibor Pál's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tibor Pál with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tibor Pál more than expected).

Fields of papers citing papers by Tibor Pál

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tibor Pál. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tibor Pál. The network helps show where Tibor Pál may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Tibor Pál, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tibor Pál Line = papers co-authored together Tibor Pál links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	In-situ, facile and green preparation of nanoscale silver supported on activated carbon: Disinfection properties and removal of inorganic DBPs from drinking water Environmental Nanotechnology Monitoring & Management ·Мар’ям Джавад Таєм, Walid Elshorbagy, Munjed A. Maraqa, Miao Ju, M Zhang, Ismail A. Elhaty, Ahmad I. Ayesh, Tibor Pál	2021	5
2	In vitro efficacy of ceftazidime-avibactam, aztreonam-avibactam and other rescue antibiotics against carbapenem-resistant Enterobacterales from the Arabian Peninsula International Journal of Infectious Diseases ·Ágnes Sonnevend, Akela Ghazawi, Jin Feng, Iqra Babar, Rayhan Hashmey, Euis Defi Iradaty, Tahir A. Rizvi, Tibor Pál	2020	26
3	Clonal emergence of Klebsiella pneumoniae ST14 co-producing OXA-48-type and NDM carbapenemases with high rate of colistin resistance in Dubai, United Arab Emirates International Journal of Antimicrobial Agents ·Carole Ayoub Moubareck, RAVI CHANDRA, Tibor Pál, Akela Ghazawi, Dalal Hammoudi Halat, AbdelNabi Basheer, M. Al-Sharhan, Zivile Valuckiene, MOSES WANJALA, Zhongyang Ma, Chia Chang Chuang, Dolla Karam Sarkis, Ágnes Sonnevend	2018	76
4	VIM-4 carbapenemase-producing Enterobacter cloacae in the United Arab Emirates Clinical Microbiology and Infection ·Ágnes Sonnevend, Akela Ghazawi, Nour Yahfoufi, Weihao Xie, Rayhan Hashmey, J. M. Hamaker, Sarah E. Wall, Tibor Pál	2012	30
5	NDM-2 carbapenemase-producing Acinetobacter baumannii in the United Arab Emirates Clinical Microbiology and Infection ·Akela Ghazawi, Ágnes Sonnevend, Rémy A. Bonnin, Laurent Poirel, Patrice Nordmann, Rayhan Hashmey, Tahir A. Rizvi, P. Amalric, Tibor Pál	2011	67
6	Comparative in vitro activity of tigecycline and other antimicrobial agents against Shigella species from Kuwait and the United Arab of Emirates Journal of Infection and Public Health ·Wafaa Jamal, Vincent O. Rotimi, Tibor Pál, Ágnes Sonnevend, C. Diaw	2010	9
7	“Gently Rough”: The Vaccine Potential of aSalmonella entericaRegulatory Lipopolysaccharide Mutant The Journal of Infectious Diseases ·Gábor Nagy, Cornelis P. van Dam, Andreas Otto, Harald Kusch, Béla Kocsis, Ulrich Dobrindt, Susanne Engelmann, Michael Hecker, Levente Emödy, Tibor Pál, Jörg Hacker	2008	27
8	CTX-M-15-producing multidrug-resistant enteroaggregative Escherichia coli in the United Arab Emirates Clinical Microbiology and Infection ·Ágnes Sonnevend, M H Najafi Mood, H. Cai, Kohinoor Ahmed, Jolanta Kolodziejek, Norbert Nowotny, Cho Ilje, M. Nur Jamaluddin, Tibor Pál	2006	28
9	Heterogeneity of Non-serotypableCampylobacter jejuniIsolates Acta Microbiologica et Immunologica Hungarica ·Ágnes Sonnevend, Tibor Pál, (unknown)	2006	2
10	The molecular epidemiology of Stenotrophomonas maltophilia bacteraemia in a tertiary referral hospital in the United Arab Emirates 2000-2004. Annals of Clinical Microbiology and Antimicrobials ·P. Jumaa, Ágnes Sonnevend, Tibor Pál, Enrique Jaime Budar López, 李捍真, 雷·额尔德尼	2006	22
11	Identification of the plasmid and the structural gene of colicin type 7 ofShigella sonnei Acta Biologica Hungarica ·E. E. Isaac, Nagnath Laxman Aavale, Tibor Pál	2005	4
12	Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, pseudin-2 Regulatory Peptides ·Tibor Pál, Ágnes Sonnevend, Sehamuddin Galadari, J. Michael Conlon	2005	49
13	Antimicrobial and cytolytic properties of the frog skin peptide, kassinatuerin-1 and its l- and d-lysine-substituted derivatives Peptides ·J. Michael Conlon, Bency Abraham, Sehamuddin Galadari, Floyd C. Knoop, Ágnes Sonnevend, Tibor Pál	2005	20
14	Comparison of Media for the Selective Culture of Enteroinvasive Escherichia coli European Journal of Clinical Microbiology & Infectious Diseases ·Wuxiong, Tibor Pál	2003	4
15	Isolation of peptides of the brevinin‐1 family with potent candidacidal activity from the skin secretions of the frog Rana boylii Journal of Peptide Research ·J. Michael Conlon, Ágnes Sonnevend, Fiona Winoto, Charles Davidson, Per F. Nielsen, Tibor Pál, Delprat	2003	61
16	A colony blot immunoassay to detect enteroinvasive Escherichia coli and Shigella in water samples Journal of Applied Microbiology ·Wuxiong, M. Verrijth, Tibor Pál	2001	9
17	Prevalence and Susceptibility of Shigella Species to 11 Antibiotics in a Kuwait Teaching Hospital Journal of Chemotherapy ·Wafaa Jamal, V.O. Rotimi, Fiona Caniglia, Tibor Pál	1998	14
18	Construction of an auxotrophic Shigella flexneri strain for use as a live vaccine Microbial Pathogenesis ·Alf A. Lindberg, Anders Kärnell, Tibor Pál, Widi Andarwati, Kjell Hultenby, B. A. D. Stocker	1990	38
19	Alpha-haemolysin, a possible virulence factor inProteus morganii FEMS Microbiology Letters ·José Javier Reyes Lagos, C. I. Buoro, Tibor Pál	1982	9
20	Research letterAlpha-haemolysin, a possible virulence factor in Proteus morganii FEMS Microbiology Letters ·Levente Emödy, Koken Sai, Tibor Pál	1982	2

About Tibor Pál

Tibor Pál is a scholar working on Endocrinology, Molecular Medicine, Microbiology, Pollution and Infectious Diseases, having authored 87 papers that have together received 2.7k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (40 papers), Escherichia coli research studies (38 papers), Viral gastroenteritis research and epidemiology (20 papers), Pharmaceutical and Antibiotic Environmental Impacts (17 papers), Salmonella and Campylobacter epidemiology (15 papers), Enterobacteriaceae and Cronobacter Research (11 papers), Antimicrobial Peptides and Activities (10 papers) and Vibrio bacteria research studies (8 papers). The work is most often cited by research in Molecular Medicine (1.1k citations), Endocrinology (1.1k citations), Applied Microbiology and Biotechnology (190 citations), Microbiology (451 citations) and Pollution (346 citations). Tibor Pál has collaborated with scholars based in United Arab Emirates, Hungary and Kuwait. Frequent co-authors include Ágnes Sonnevend, Akela Ghazawi, J. Michael Conlon, Rayhan Hashmey, Vincent O. Rotimi, Wafaa Jamal, Sanjukta Ghosh, Thomas L. Hale, Surojit Pande and Snigdhamayee Praharaj. Their work appears in journals such as Journal of Clinical Microbiology, Journal of Medical Microbiology, International Journal of Antimicrobial Agents, International Journal of Infectious Diseases and Diagnostic Microbiology and Infectious Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact